Asian Pacific Journal of Cancer Prevention · 2013 · 57 citations · 20 references
MedicineOncologyOral PathologyMolecular OncologyNeoplasiaSalivary Gland DisordersBenign Salivary Gland TumorsMalignant Salivary Gland TumorsSalivary Gland CancerSalivary Gland CytologySalivary Gland MalignanciesSalivary Gland PathologyImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingSalivary Cancer BiomarkersSalivary Gland Tumor CytologySalivary Gland Tumor DiagnosisSalivary Gland Tumor Evaluation
BACKGROUND: Proliferation markers widely have been used to diagnose and determine the behaviour and prognosis of benign and malignant tumours. Minichromosome maintenance 3 (MCM3) is a novel proliferation marker. The aim of this study was to evaluate and compare MCM3 with Ki-67 in diagnosis of salivary gland tumours. MATERIALS AND METHODS: In this retrospective study, immunohistochemical expression of MCM3 and Ki-67 was evaluated in 15 pleomorphic adenomas (PA), 17 mucoepidermoid carcinomas (MEC) and 18 adenoid cystic carcinomas (ADCC) . Labeling indices (LIs) for the two markers were calculated and compared. RESULTS: MCM3 and Ki-67 LIs were significantly higher in MEC and ADCC compared to PA. The LI of MCM3 was significantly higher than that of Ki-67 in MEC and PA. There was no significant difference between the two markers in ADCC. A cut-off point of 8% with 74.3% sensitivity and 93.3% specificity for MCM3 was obtained to discern between benign and malignant tumors. CONCLUSIONS: These results suggest that MCM3 might be a useful proliferation marker for differential diagnosis and recognition of clinical behavior of salivary gland tumors.
20
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy.
A. Freeman, Laurel Morris, Anthony D. Mills et al. · PubMed · 1999 · 326 citations
Medicine, Cell Biology, Pathology +17